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Available online 12 April 2016The major challenge in pre-surgical epileptic patient evaluation is the correct identiﬁcation of the seizure onset
area, especially in MR-negative patients. In this study, we aimed to: (1) assess the concordance between per-
fusion, from ASL, and metabolism, from 18F-FDG, acquired simultaneously on PET/MR; (2) verify the utility of a
statistical approach as supportive diagnostic tool for clinical readers. Secondarily, we compared 18F-FDG PET
data from the hybrid PET/MR systemwith those acquiredwith PET/CT,with the purpose of validate the reliability
of 18F-FDG PET/MR data.
Twenty patients with refractory focal epilepsy, negative MR and a deﬁned electro-clinical diagnosis underwent
PET/MR, immediately followed by PET/CT. Standardized uptake value ratio (SUVr) and cerebral blood ﬂow
(CBF) mapswere calculated for PET/CT-PET/MR and ASL, respectively. For all techniques, z-score of the asymme-
try index (zAI) was applied for depicting signiﬁcant Right/Left differences. SUVr and CBF images were ﬁrstly
visually assessed by two neuroimaging readers, who then re-assessed them considering zAI for reaching a ﬁnal
diagnosis.
High agreement between 18F-FDG PET/MR and ASL was found, showing hypometabolism and hypoperfusion
in the same hemisphere in 18/20 patients, while the remaining were normal. They were completely concordant
in 14/18, concordant in at least one lobe in the remaining. zAI maps improved readers' conﬁdence in 12/20 and
15/20 patients for 18F-FDG PET/MR and ASL, respectively. 18F-FDG PET/CT-PET/MR showed high agreement,
especially when zAI was considered.
The simultaneous metabolism-perfusion acquisition provides excellent concordance on focus lateralisation and
good concordance on localisation, determining useful complementary information.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Epilepsy is the most frequent serious chronic neurological condition
(Sander, 2003), and despite advancements in antiepileptic drug thera-
py, one-third of patients remain poorly controlled on drug treatment.
In patients suffering from focal seizures, surgical operation aiming toine, University College London,
azzo@univr.it (I. Boscolo
. This is an open access article underremove the seizure onset zone (SOZ) may represent the only available
option for becoming seizure-free. If an abnormality can be detected on
structural magnetic resonance imaging (MR), and is concordant in
localisation with the electro-clinical diagnosis, there is usually a 2/3
chance of achieving seizure freedom (Wiebe et al., 2001). However,
the odds for seizure freedom are less good if MR is either inconclusive
or doesn't reveal structural brain lesions (De Tisi et al., 2011).
In these patients, intracranial EEG recording (iEEG) remains the
“gold standard” diagnostic procedure for localising the SOZ and plan-
ning surgical resection. Subdural or depth electrodes have to be precise-
ly positioned and limited to speciﬁc brain region, in order to minimizethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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neurosurgeon requires a reliable diagnostic hypothesis about the
localisation of epileptic focus aided by complementary information
from different examinations before performing any invasive procedure
or even resection of brain tissue appearing normal onMR (Rheims et al.,
2013). In this context, functional neuroimaging techniques can provide
additional and supportive information about the localisation of the SOZ
andmay lead to more targeted iEEG investigations if deemed necessary
(Brodbeck et al., 2010).
Indeed, the electric changes occurring in the SOZ are often associated
with alterations of perfusion and metabolism around the areas of seizure
onset and spread. Perfusion single photon emission computed tomogra-
phy (SPECT) has been successfully employed since the 1980s to assess re-
gional cerebral blood ﬂow (CBF) changes related to the presumed focus,
showing ictal hyperperfusion or interictal hypoperfusion (Weil et al.,
2001; Calcagni et al., 2002). In light of the several limitations of perfusion
SPECT studies, the interest in alternative non-invasive MR-based perfu-
sion techniques, such as Arterial Spin Labeling (ASL), has grown over
the last years. ASL provides a fully quantitative measure of regional CBF
using arterial bloodwater magnetically labeled by radiofrequency pulses,
proximal to the tissue of interest, as an endogenous diffusible tracer
(Williams et al., 1992; Detre et al., 1992; Alsop et al., 2015). Despite the
high number of ASL sequences currently available and the limited studies
in epilepsypatients, ASLdid showpromising results, elucidating interictal,
ictal andpost-ictal alterations in epileptic brain andhemispheric hemody-
namic asymmetry (Wolf et al., 2001; Lim et al., 2008; Pizzini et al., 2013;
Storti et al., 2014; Boscolo Galazzo et al., 2015; Sierra-Marcos et al., 2016).
[18F]-ﬂuoro-deoxy-D-glucose (18F-FDG) positron emission tomogra-
phy (PET)/computed tomography (CT) is currently considered the lead-
ing imaging modality for the presurgical metabolic assessment during
the interictal phase for both temporal (Drzezga et al., 1999; Rathore
et al., 2014) and extra-temporal lobe epilepsy (Kim et al., 2000; Juhász
et al., 2003), showing regional hypometabolism being associated with
the presumed focus. Recently, PET/MR systems have been successfully in-
troduced in clinical practice for the simultaneous acquisition of PET and
MR (Catana et al., 2010; Fraioli and Punwani, 2014; Zhang et al., 2014;
Ding et al., 2014), providing not only directly superimposable functional
andmorphological data, but also a proper comparison of differentmodal-
ities under identical conditions, something that might be essential in dy-
namic pathologies that rapidly change over time, such as epilepsy.
Due to the complexity and variability in the localisation of the
epileptic focus, the clinical relevance of different functional alter-
ations needs to be assessed at the individual patient level. Statistical
Parametric Mapping [SPM; Wellcome Department of Cognitive Neu-
rology, London, UK] (Friston et al., 1994) and 3D-SSP/Neurostat
(Minoshima et al., 1995) are widely used for semi-quantitatively
comparing an individual patient to an age-matched normal data-
base, in order to identify areas of statistically altered metabolism
or perfusion (Barnes et al., 2000; Kim et al., 2002; Kumar et al.,
2010; Archambaud et al., 2013). Nevertheless, unlike 18F-FDG PET/
CT, large datasets from normal subjects are not yet available for
18F-FDG PET/MR, precluding the possibility to compare patient
data to controls and to provide a statistical evaluation of individual
patient data. As an alternative, for quantifying the differences between
hemispheres in focal epilepsy some authors have proposed the applica-
tion of the Asymmetry Index (AI) parameter, usually comparing AI
values over the presumed focus and homotopic regions (Leiderman
et al., 1992; Duncan et al., 1993; Theodore et al., 1997).
In this study, we investigated the potential role of a hybrid PET/MR
system in a well characterized group of patients with refractory focal
epilepsy, primarily aiming to: (1) evaluate perfusion, assessed by ASL,
and metabolism, assessed by 18F-FDG, also in relation to the electro-
clinically deﬁned SOZ; and (2) evaluate the diagnostic usefulness of an
individually tailored approach based on the AI calculation for the auto-
matic identiﬁcation of signiﬁcant hemispheric asymmetries in each
patient.In addition, since their different photon attenuation correction, we
aimed to compare 18F-FDG PET data from the hybrid PET/MR system
with those acquired with PET/CT for investigating the reliability of
PET/MR and to determine if it yields additional information beyond
that of PET/CT, still considered as “gold standard”.
2. Materials and methods
2.1. Patients
Twenty consecutive patients with refractory focal epilepsy (10men,
mean age 34 ± 12 years), undergoing presurgical assessment between
March 2013 and October 2014, were enrolled in our study.
The inclusion criteria were: (1) drug-resistant focal epilepsy;
(2) negative structural high-resolution 3T-MR scans; (3) well-deﬁned
electro-clinical localisation of seizure-onset through ictal/interictal elec-
troencephalogram and video-telemetry (VT-EEG).
Exclusion criteriawere: abnormalities on structuralMR images, con-
traindications for MR examinations, concomitant presence of other
non-epilepsy neurological disorders, and pregnancy. Patientswho satis-
ﬁed the above criteria underwent simultaneous PET/MR examination
and, immediately after, a PET/CT scan using the 18F-FDG activity previ-
ously injected.
Electro-clinical diagnostic hypothesis was reached by a multi-
disciplinary team (MDT) of neurologists, neurophysiologists, neuro-
radiologists, psychologists and psychiatrists based on clinical history,
neuropsychological assessment and electrophysiological ﬁndings from
VT-EEG monitoring.
The study was approved by the Northeast-Newcastle and North
Tyneside 1 Research Ethics Committee and carried out in accordance
with the Declaration of Helsinki of the World Medical Association. All
patients gave informed consent prior to entering the study.
Patient demographics and clinical characteristics are reported in
Table 1.
2.2. PET/MR and 18F-FDG PET/CT acquisition
All patients, fasted for at least 6 h and with the serum glucose level
below 7 mmol/l, rested in a dark quiet room and were injected with a
bolus of 18F-FDG (range activity 221–292 MBq). 30 min after injection,
patientswere placed into the PET/MR scanner (BiographmMR, Siemens
Healthcare, Erlangen, Germany) and immobilized with the head coil
and speciﬁcally designed minimally attenuating pads.
PET/MR protocol started with the acquisition of ultra-short echo
time (UTE) sequences in order to calculate a μ-map for attenuation cor-
rection [echo times (TE) TE1: 0.07 ms; TE2: 2.46 ms; repetition time
(TR): 11.9 ms, ﬂip angle: 10°, slice thickness: 1.6 mm; scan duration:
1:40 min] (Dickson et al., 2014; Burgos et al., 2014). At an average
time of 35 ± 4 min after 18F-FDG injection, a 3D-brain 18F-FDG PET
scan was acquired in list mode [voxel size: 1.40 × 1.40 × 2.03 mm3; re-
construction: 3 iterations, 21 subsets, 3D Gaussian ﬁlter (3.5 mm
FWHM); scan duration: 15 min]. During PET data acquisition, ASL data
were collected simultaneously. The manufacturer's pulsed PICORE
(proximal inversion with a control for off-resonance effects) ASL se-
quence with Q2TIPS scheme (QUIPSS II with Thin-slice TI1 Periodic
Saturation) and 2D-echo planar imaging readout was used [voxel size:
3.6 × 3.6 × 5 mm3; gap: 1 mm; 19 slices; TI1/TIs/TI2: 800/1200/
1800 ms; TR/TE: 2860/17 ms; 201 volumes; total acquisition time:
9:36 min]. Standard MR sequences [T2-weighted image, 3D T1-
weighted MPRAGE, 2D FLAIR (coronal and axial planes)] were also ac-
quired as part of the PET/MR clinical epilepsy protocol.
Following PET/MR, all patients underwent PET/CT examination with
the smallest possible temporal delay. 18F-FDG PET/CT data were
acquired on VCT PET/CT systems (GE Healthcare Systems, Waukesha,
WI) at an average time of 101.1min (range 65–140min) after injection.
Patients were immobilized with a head restraint using straps and a
Table 1
Clinical proﬁle: gender, age, seizures characteristics, antiepileptic therapy, and electro-clinical diagnosis from the multi-disciplinary team (MDT) established on the basis of clinical
information and electrophysiological ﬁndings.
Pt n° Sex Age Years since beginning Type of seizures Seizures frequency Relevant history Current antiepileptic therapy MDT
1 F 30 20 Complex partial 12/month Negative CBZ, LEV Right temporal
2 F 28 25 Complex partial 4–6/day Negative LTG, PG, PRP Right temporo-parietal
3 F 40 20 Simple partial with SG 7/month; 1/year (SG) Febrile convulsion CBZ, PG Right temporal
4 F 44 30 Complex partial SG 3–20/month; 1/year (SG) Meningitis LEV Right temporal
5 M 23 3 Simple partial 1–2/week Febrile convulsion ESL Right parietal
6 M 39 14 Simple partial with SG 1–2/week; rare (SG) Negative LTG, LEV, RTG Left fronto-temporal
7 F 39 18 Simple partial with SG 1–5/daily; rare (SG) Negative OCX, CLZ, PHE Left fronto-temporal
8 M 22 6 Complex partial with SG 6–8/month; 1–3/month (SG) Negative ZNS, LEV, CLZ Left temporo-parietal
9 M 19 15 Simple partial with SG 1–2/week; 1–2/month (SG) Negative CLZ, OCX, LEV Right fronto-temporal
10 F 33 17 Complex partial 1–2/week Negative LTG, ZNS Left temporo-occipital
11 F 19 5 Complex partial with SG 4–5/day; 2–3/week (SG) Negative LTG, LEV, ZNS, OCX Left frontal
12 M 23 14 Complex partial 1/day Negative VPA, ESL, TPM, LEV Left frontal
13 M 23 19 Simple partial 2–3/night Negative ZNS, LEV, CLZ Right frontal
14 M 65 16 Complex partial 1/day Negative VPA, LTG Left temporal
15 F 41 17 Complex partial 2–3/day Negative ZNS, ESL, CLZ Right temporal
16 M 31 15 Simple partial with SG 2/month; rare (SG) Negative LEV, LCM Right temporal
17 M 38 8 Complex partial with SG 1–2/month; rare (SG) Negative OCX. CLZ, ZNS, VPA Left temporal
18 F 55 49 Complex partial 2–3/week Negative VPA, CBZ, CLZ, ZNS Right fronto-temporal
19 F 39 30 Complex partial Several/week Negative OCX, TPM, CLP, CLZ Left temporal
20 M 40 7 Complex partial 3/week Negative CBZ, LTG Right temporal
SG= secondary generalization; CBZ= carbamazepine; LEV= levetiracetam; LTG= lamotrigine; PG=pregabilin; PRP= parampanel; ESL= eslicarbazepine; RTG= retigabine; OCX=
oxocarbazepine;CLZ = clobazam; PHE = phenytoin; ZNS = zonisamide; VPA = valproate; TPM= topiramate; LCM= lacosamide; CLP = clonazepam.
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1.95 × 1.95 × 3.27 mm3; reconstruction: 3 iterations, 20 subsets, 3D
Hanning ﬁlter (cut-off 4 mm); scan duration: 15 min]. Additionally,
for attenuation and scatter correction, an unenhanced low-dose CT
scan (140 kVp, 80 mA, 0.8 s, pitch 1.75/1.375) was obtained.2.3. ASL and PET data analysis
ASL data were preprocessed and analyzed using FSL 5.0.1 (FMRIB,
Oxford, UK) andMatlab 7.14 (MathWorks, Natick,MA)with a dedicated
in-house code developed for this study. Motion correction was applied
separately to the Control and Label volumes using the MCFLIRT
tool in FSL and taking the ﬁrst volume as reference. In particular, a
six-parameter 3D rigid-body registration with a normalized correla-
tion cost function was used. The ﬁrst volume, which represents the
ASL calibration scan, was also used for estimating the coregistration
parameters from ASL to the individual T1-weighted image by applying a
3D rigid-body registration with a normalized mutual-information cost
function and 7 degrees of freedom. After computing the mean Control-
Label over the multiple repetitions, quantiﬁcation of CBF maps was per-
formed according to the recently published guidelines (Alsop et al.,
2015). CBF maps in ASL space were afﬁne-registered to the individual
high-resolution anatomical images by applying the previously estimated
transformation matrix. Each T1-weighted image was then registered to
theMNI (Montreal Neurological Institute) space with 1 × 1 × 1mm3 res-
olution using a non-linear method (FNIRT tool in FSL). Finally, the joint
ASL/T1-weighted and T1-weighted/MNI space transformation parame-
ters were used to spatially normalize the CBF maps, which were then
smoothed with a 2 mm FWHM Gaussian kernel.
18F-FDG data acquired with PET/CT and PET/MR were corrected
for photon attenuation and registered to individual high-resolution
anatomical images, using normalized mutual information as the cost
function and 7 degrees of freedom. The joint PET/T1-weighted and T1-
weighted/MNI space transformation parameters were used to spatially
normalize the PET data. PET data in MNI space were transformed into
maps representing the standardized uptake value ratio (SUVr) which
is deﬁned as the tissue concentration of radioactivity (kBq/ml) in each
voxel normalized to the mean activity concentration in a reference re-
gion, here represented by the cerebellum. In particular, a gray matter
(GM) cerebellum mask was manually delineated on the spatially nor-
malized individual T1-weighted image and then applied to PET data inthe same space to calculate the mean activity concentration in the
reference region.
2.4. Evaluation of metabolic/perfusion abnormalities with the asymmetry
index
The normalization of ASL and 18F-FDG PET datasets to the same stan-
dard coordinate space allowed a voxelwise comparison betweenmodali-
ties as well as identiﬁcation of Left/Right asymmetries in the cerebral
hemispheres and the cortical lobes. Assuming the epileptic focus was lo-
cated in one hemisphere, as our population of patients with focal seizures
was well-selected, a signiﬁcant difference in metabolism/perfusion be-
tween the abnormal area and the corresponding location in the opposite
hemisphere would be expected.
Therefore, in order to identify the voxels potentially corresponding
to the epileptic focus we deﬁned for both CBF and SUVr maps of each
patient a voxelwise AI as:
AI ¼ 100  Right−Left½ = Rightþ Leftð Þ=2½ : ð1Þ
This was calculated for every voxel in the Right hemisphere, with
positive values indicating Right N Left and negative values Right b Left
(Lim et al., 2008; Duncan et al., 1993; Theodore et al., 1997).
After calculating themean (μAI) and standard deviation (SDAI) of the
whole set of AI values, a voxelwise AI z-score map (zAI) was derived as:
zAI ¼ valueAI−μAISDAI
: ð2Þ
Assuming a normal distribution of values, voxels with |zAI| ≥ 1.64 cor-
responding to p b 0.05 were considered to have signiﬁcantly different
SUVr or CBF between hemispheres. For visualization purposes, brain
voxels with statistically signiﬁcant asymmetric metabolism/perfusion
were displayed on the Right hemisphere if zAI ≤ −1.64 (Right b Left)
and on the Left hemisphere if zAI ≥ 1.64 (Right N Left).
2.5. Clinical interpretation of 18F-FDG PET/CT, 18F-FDG PET/MR and ASL data
Two imaging specialistswith several years' experience in neuroradi-
ology and nuclear medicine (F.F., 10 years; F.B.P., 11 years), unaware of
clinical data, visually evaluated the normalized 18F-FDG PET/CT, 18F-FDG
PET/MR and ASL images in the same way a week apart, in order to
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grade the level of overall scan as normal, or abnormal. Second, readers
were instructed to report more extensive details on brain metabolism/
perfusion, encompassing the main involved brain lobes (i.e., frontal,
temporal, parietal, occipital), in order to lateralise and localize the al-
tered patterns, if present.
Afterwards, the two readers re-examined the images taking into
account the corresponding zAI maps showing clusters of signiﬁcant
hemispheric asymmetries. Based on these statistical results and the
original images, the ﬁnal report regarding lateralisation/localisation of
the presumed epileptic focus was made (visual + zAI). Any disagree-
ment between the two readerswas resolved by consulting a third senior
neuroradiologist/nuclear medicine physician.
2.6. Comparison between 18F-FDG PET/CT and 18F-FDG PET/MR ﬁndings
The visual assessment and the ﬁnal decision (visual + zAI) of 18F-
FDG PET/CT and PET/MR from the two readers in consensus were com-
pared in each patient. Moreover, the level of agreement between the
two modalities for each of the two reports (visual and visual + zAI)
was quantiﬁed by a Kappa test deﬁned as:
K ¼ Po−Peð Þ= 1−Peð Þ ð3Þ
where Po = observed proportional agreement, Pe = random pro-
portional agreement. Interpretation of the level of agreement was as
follows: 0.0–0.2 slight; 0.2–0.4 fair; 0.4–0.6moderate; 0.6–0.8 substantial;
0.8–1.0 almost perfect (Richard Landis and Koch, 1977).
Regarding image quantiﬁcation results, Pearson's correlation
coefﬁcient (r) was calculated for each patient between all the AI
values from the two modalities, in order to compare on a voxel-
by-voxel basis the degree of hemispheric asymmetry estimated
with the two techniques. Further, the zAI values of the voxels classi-
ﬁed as having signiﬁcantly different SUVr between hemispheres for
18F-FDG PET-CT and PET-MR were compared using an unpaired
t-test, with statistical signiﬁcance determined as p b 0.05. The
mean and standard deviation of these zAI values over the statistical
threshold were also calculated in each patient.
To specify regional correlations across patients, the SUVr maps from
18F-FDG PET/CT and PET/MRwere comparedwithin ten regions of inter-
est (ROIs) based on the Harvard-Oxford atlases and commonly assessed
in neurological studies: the hippocampus, cerebellum, insula, thalamus,
frontal lobes, temporal lobes, occipital lobes, parietal lobes, striata and
precuneus. In particular, the mean SUVr values for 18F-FDG PET/CT
and PET/MR were extracted from the ten ROIs in each patient, which
were correlated across the twenty subjects using Pearson's correlation
coefﬁcients (r). Further, the mean SUVr values of the ten ROIs were
compared using paired t-test (p b 0.05).
All these preliminary analyses were focused on amore technical and
direct comparison of 18F-FDG PET data acquired with two different
systems, in order to assess the reliability of 18F-FDG PET/MR, indepen-
dently from the diagnosis of epilepsy, and considering 18F-FDG PET/CT
as “gold standard”.
2.7. Comparison between 18F-FDG PET/MR and ASL ﬁndings
After the preliminary direct comparison between 18F-FDG PET/CT
and PET/MR data, all subsequent analyses were focused on 18F-FDG
PET/MR and ASL data simultaneously acquired with the PET/MR scan-
ner. For these imaging modalities, besides the two consensus reports
(visual and visual + zAI), the impact of the statistical zAI maps on the
conﬁdence of imaging reporting was also noted in order to quantify
the effectiveness of this method as a decision aid. In particular, the
readers' conﬁdence after the presentation of the zAI maps was assigned
to one of the following categories: Unchanged and Improved.The ﬁnal decisions for 18F-FDG PET/MR and ASL data (visual + zAI)
were qualitatively compared in order to evaluate the concordance
between changes inmetabolism and perfusion in each epileptic patient.
The level of agreement between theﬁnal decisions coming from the two
modalities was also quantiﬁed using the Kappa test as previously de-
scribed (Eq. (3)).
Subsequently, 18F-FDG PET/MR and ASL imaging results were statis-
tically compared in terms of cross-subject regional correlations within
the ten ROIs as deﬁned in the previous paragraph. In particular, for
ASL the CBFmaps of each patient were voxel-wise intensity normalized
to the mean CBF in the same cerebellum mask as for the 18F-FDG PET/
MR data, in order to generate relative CBF maps (rCBF) which were
more suitable for the inter-modality statistical comparison. Thus, the
mean rCBF and SUVr values were extracted from the different ROIs,
which were then correlated across the twenty patients using
Spearman's rank correlation coefﬁcients (rs value). Further, the mean
rCBF and SUVr values in the same brain regions were statistically com-
pared using a Wilcoxon signed-rank test (p b 0.05).
2.8. Comparison of electro-clinical diagnostic hypothesis with 18F-FDG
PET/MR and ASL
For each modality separately, the level of agreement between each
of the two consensus reports (visual and visual + zAI) and the electro-
clinical diagnosis established by MDT was assessed using the Kappa
test as described by Eq.(3), which also allowed to indirectly quantify
the usefulness of the zAI method.
The overall information provided by the combination of 18F-FDG
PET/MR and ASL results, considered as a unique technique, was also
qualitative compared to the electro-clinical MDT diagnosis to assess
the performance of the simultaneous multimodal approach.
3. Results
All patients completed the full investigative protocol: none of them
reported any seizure onset, i.e. all patients were evaluated during the
interictal phase, and no irregular major movements were detected dur-
ing the acquisitions.
Clinical information andMDT electro-clinical diagnosis of the epileptic
focus are summarized in Table 1. Figs. 1 and 2 present imaging results
from a selection of 12 representative patients (6 with a presumed Right
hemisphere epileptic focus and 6 with a presumed Left hemisphere epi-
leptic focus), showing the semiquantitative SUVr maps for PET data and
the quantitative CBF maps for ASL, along with the corresponding zAI.
The main 18F-FDG PET/CT, 18F-FDG PET/MR and ASL results are
summarized in Tables 2 to 4. In particular, Table 2 includes the results
from the statistical analyses between 18F-FDG PET/CT-PET/MR across
all the patients, while in the Supplementary material Table 1 the main
imaging and statistical ﬁndings for these two techniques are reported
on an individual basis. Finally, imaging and statistical comparisons be-
tween 18F-FDG PET/MR and ASL are summarized in Tables 3 and 4.
3.1. Comparison between 18F-FDG PET/CT and 18F-FDG PET/MR ﬁndings
Visually, 18F-FDG PET/CT and 18F-FDG PET/MR showed hypo-
metabolism in the same 17/20 patients, and both were normal in
the remaining (Supplementary Table 1). In particular, 18F-FDG PET/CT
and 18F-FDG PET/MR were concordant in lateralising abnormalities to
the same side in 17/17 patients and in localising to the same lobe in 15/
17 patients. In the remaining 2 patients (#8 and #14) 18F-FDG PET/MR
and 18F-FDG PET/CTwere partially concordant, with at least one common
region identiﬁed.
Accounting for 18F-FDG zAI statistical maps, 18F-FDG PET/CT and 18F-
FDG PET/MR showed hypometabolism concordant for lateralisation and
localisation in the same 17 patients plus a further patient (#4)whowas
visually classiﬁed as normal. Thus, 18F-FDG PET/CT and 18F-FDG PET/MR
Fig. 1. 18F-FDGPET/CT, 18F-FDGPET/MR, ASL and the corresponding zAI statisticalmaps for some representative patientswith a Right hemisphere focal localisation (normalizeddata). SUVr
and CBF maps for two slices of interest encompassing the presumed focus are reported for 18F-FDG PET and ASL, respectively.
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ations (Supplementary Table 1). The statistical Kappa test conﬁrmed an
almost perfect agreement between 18F-FDG PET/CT and 18F-FDG PET/
MR results for visual assessment (K = 0.845), and perfect agreement
(K = 1) for the visual + zAI report.
Voxel-by-voxel comparison between the AI values of 18F-FDG PET/
CT and of 18F-FDG PET/MR showed signiﬁcant correlation in all cases,
with p b 0.0005 in each patient, and an overall mean correlation coefﬁ-
cient of r= 0.91 ± 0.05 (Supplementary Table 1). Moreover, consider-
ing only voxels with statistical signiﬁcant zAI values, no statistically
signiﬁcant differences were found between 18F-FDG PET/CT and 18F-
FDG PET/MR zAI values (p N 0.05).
Scatter plots of the mean SUVr values from 18F-FDG PET/CT and
18F-FDG PET/MR in a series of ROIs are presented in Fig. 3A. The overall
correlation across twenty patients in the ten ROIs was strong (r=0.85,
p b 0.0005), with all the ROIs showing signiﬁcant results (p b 0.0005)
and Pearson's correlation coefﬁcients over r = 0.68 (Table 2). When
testing the differences between the mean 18F-FDG PET/CT and 18F-
FDG PET/MR SUVr values, 4 ROIs (occipital and parietal lobes, thalamus,
hippocampus) showed a statistically signiﬁcant difference (Table 2).
3.2. Comparison between 18F-FDG PET/MR and ASL ﬁndings
Visually, 18F-FDG PET/MR showed hypometabolism in 17/20
patients, while in the remaining 3 patients 18F-FDG PET/MR did not
show any marked metabolic abnormality (Table 3, Figs. 1 and 2). After
consultation of 18F-FDG zAI maps, the readers identiﬁed hypometabolic
areas in one additional patient, while in the remaining 2 patients (#2
and #5), no statistical signiﬁcant asymmetries were identiﬁed on the zAI
maps and thus remained classiﬁed as normal. The addition of 18F-FDGzAI maps to the visual assessment improved the readers' conﬁdence in
image reporting in 12/20 patients. In particular, in patients #4 and #8
the information from the zAI maps allowed to highly increase the readers'
conﬁdence,which changed theirﬁnal decisionwhen reassessed the imag-
ing maps.
Visually, ASL images showed hypoperfusion in 17/20 patients, while
in the remaining 3 patients ASL did not show any marked perfusion
abnormality (Table 3, Figs. 1 and 2). After consultation of ASL zAI
maps, the readers identiﬁed hypoperfused areas in one additional pa-
tient, while in the remaining 2 (#2 and #5) no statistical signiﬁcant
asymmetries were identiﬁed on the zAI maps and thus remained classi-
ﬁed as normal. The ASL zAI maps improved the readers' conﬁdence in
15/20 patients, in particular in patients #4 and #7 they led to a change
in the ﬁnal diagnosis when reassessing the CBF maps.
Comparing the two modalities' ﬁndings and focusing on the ﬁnal
decision (visual + zAI report) performed by the two readers, 18F-FDG
PET/MR and ASL both showed functional changes in 18/20 patients,
while they were both normal in the remaining. In the 18 patients with
focally reduced perfusion and metabolism, the two techniques were
concordant regarding lateralisation in all 18/18 patients, and regarding
localisation in 14/18 patients. We observed partial concordance in the
remaining 4 patients, showing coexistence of metabolism-perfusion
coupled/uncoupled patterns (Table 3). The statistical Kappa test con-
ﬁrmed a substantial agreement in ﬁnal decision between 18F-FDG PET/
MR and ASL results (K = 0.723).
Scatter plots of themean SUVr and rCBF values from 18F-FDG PET/MR
and ASL in a series of ROIs are presented in Fig. 3B. The overall correlation
across twenty patients in the ten ROIs was good (rs = 0.49, p b 0.0005),
with signiﬁcant Spearman correlation coefﬁcients for 5ROIs (frontal, tem-
poral and parietal lobes, striata and hippocampus). Conversely, low
Fig. 2. 18F-FDG PET/CT, 18F-FDG PET/MR, ASL and the corresponding zAI statistical maps for some representative patients with a Left hemisphere focal localisation (normalized data). SUVr
and CBF maps for two slices of interest encompassing the presumed focus are reported for 18F-FDG PET and ASL, respectively.
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differences between the mean SUVr and rCBF values, 5 ROIs (occipital
and parietal lobes, striata, thalamus, precuneus) showed a statistically sig-
niﬁcant difference (Table 4).
3.3. Comparison of electro-clinical diagnostic hypothesis with 18F-FDG PET/
MR and ASL
Regarding the localisation of epileptic focus, the hypometabolic
areas visually identiﬁed by 18F-FDG PET/MR were in agreement with
electro-clinical MDT diagnosis in 13/20 patients. After 18F-FDG zAI
maps consultation, areas of hypometabolism were concordant with
MDT in 15/20 patients (Table 3). These ﬁndings were conﬁrmed by
statistical Kappa test that showed a moderate agreement betweenTable 2
Cross subject Pearson's r correlation (column 1) and t-test results (column 2 and
3) between SUVr of 18F-FDG PET/CT and SUVr of 18F-FDG PET/MR in 10 regions of interest.
Region of interest Correlation t-value p-Value
Frontal 0.85 2.01 0.051
Temporal 0.89 1.48 0.147
Occipital 0.68 2.53 0.015
Parietal 0.72 2.30 0.027
Cerebellum 0.94 0.63 0.530
Striata 0.83 −1.34 0.195
Thalamus 0.82 −4.18 0.002
Hippocampus 0.80 −6.24 0.000
Insula 0.93 −0.26 0.935
Precuneus 0.80 1.10 0.280
p-Value for Pearson's r correlation coefﬁcient was b0.0005 in each regionvisual 18F-FDG PET/MR and MDT (K = 0.514), substantially improved
by the consultation of the zAI maps (K = 0.650).
For ASL, the areas of hypoperfusion visually identiﬁed on the CBF
maps concurred with the electro-clinical data in 11/20 patients. After
ASL zAI maps consultation, ASL was concordant in a further 2 patients
(#4 and #7, Table 3). The statistical kappa test showed a moderate
agreement between ASL visually assessed and MDT (K = 0.406), that
became stronger after the consultation of zAI maps (K = 0.532).
In regards to the combined complementary information provided by
18F-FDG and ASL, there was a perfect agreement in lateralisation and
localisation among 18F-FDG, ASL and MDT in 12/20 patients; in one
case (patient #7), the combination of 18F-FDG and ASL allowed to
reach a perfect agreementwith the electro-clinical diagnosis. In one fur-
ther patient (#6), while the electro-clinical diagnosis was widespread,
the combination of 18F-FDG and ASL showed a more focal area of func-
tional alteration. Conversely, in 4/20 patients a reverse pattern was
seen, with the combination of 18F-FDG and ASL showing a more wide-
spread area of functional alterations in comparison to MDT (Table 3).
4. Discussion
We report the ﬁrst simultaneously acquired investigation of the re-
lationship between metabolic and perfusion data using a hybrid PET/
MR scanner in patients with refractory focal epilepsy. In this group of
difﬁcult-to-treat patients with negative structural MR, 18F-FDG PET/
MR and ASLwere able to identify regions ofmetabolic and perfusion ab-
normality in the majority of the patients, showing complete agreement
in lateralising seizure onset, a complete agreement in localising seizure
onset area in 14/20 patients and partial concordance with at least one
Table 3
18F-FDG PET/MR and ASL results: visual assessment, ﬁnal decision after zAI consultation (visual + zAI) and readers' conﬁdence in their decision after image reassessment with zAI
information. The electro-clinical diagnosis about focus localisation from the multi-disciplinary team (MDT) is also reported.
Pt n° MDT 18F-FDG PET/MR
visual
18F-FDG PET/MR
visual + zAI
Readers' conﬁdence
after zAI maps
ASL visual ASL visual + zAI Readers' conﬁdence
after zAI maps
1 Right temporal Right temporal Right temporal Unchanged Right temporal Right temporal Unchanged
2 Right temporo-parietal Normal Normal – Normal Normal –
3 Right temporal Right temporal Right temporal Improved Right temporal Right temporal Improved
4 Right temporal Normal Right temporal Improved (*) Normal Right temporal Improved (*)
5 Right parietal Normal Normal – Normal Normal –
6 Left fronto-temporal Left temporal Left temporal Unchanged Left temporal Left temporal Unchanged
7 Left fronto-temporal Left temporal Left temporal Improved Left temporal Left fronto-temporal Improved (*)
8 Left temporo-parietal Left temporal Left temporo-parietal Improved (*) Left fronto-parietal Left fronto-parietal Improved
9 Right fronto-temporal Right fronto-temporal Right Fronto-Temporal Improved Right fronto-temporal Right fronto-temporal Improved
10 Left temporo-occipital Left temporo-occipital Left temporo-occipital Unchanged Left temporo-occipital Left temporo-occipital Improved
11 Left frontal Left frontal Left frontal Unchanged Left fronto-parietal Left fronto-parietal Improved
12 Left frontal Left frontal Left frontal Unchanged Left fronto-parietal Left fronto-parietal Improved
13 Right frontal Right frontal Right frontal Unchanged Right frontal Right frontal Unchanged
14 Left temporal Left fronto-temporal Left fronto-temporal Improved Left fronto-temporal Left fronto-temporal Improved
15 Right temporal Right temporal Right temporal Improved Right temporal Right temporal Improved
16 Right temporal Right temporal Right temporal Improved Right temporal Right temporal Improved
17 Left temporal Left temporal Left temporal Improved Left temporal Left temporal Improved
18 Right fronto-temporal Right fronto-temporal Right fronto-temporal Improved Right fronto-temporal Right fronto-temporal Improved
19 Left temporal Left temporal Left temporal Improved Left temporal Left temporal Improved
20 Right temporal Right temporal Right temporal Improved Right temporal Right temporal Improved
(*) Readers conﬁdence has been highly improved by the zAI consultation (i.e. they changed their initial judgment)
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these non-invasive techniques provided concordant and, in some
cases, complementary information which allowed conﬁrmation of
the electro-clinical diagnosis formulated by a multi-disciplinary panel
that integrates seizure semiology, long-term VT-EEG and structural neu-
roimaging, using clinical experience. In themanagement of thesepatients,
it is of great importance to have reliable diagnostic imaging tools that
would be able to conﬁrm and add conﬁdence in the clinical diagnostic hy-
pothesis, helping the clinician and neurosurgeon in the selection of the
best therapeutic approach.
In our study, we primarily investigated whether 18F-FDG PET and
ASL data, simultaneously acquired with a hybrid PET/MR system, were
able to identify regional abnormalities possibly related to the epileptic
focus, and if metabolism and perfusion alterations were effectively
coupled in the interictal period. In the last years, multiparametric func-
tional imaging modalities became essential tools in the diagnostic eval-
uation of epilepsy although, in everyday clinical practice, the acquisition
of functional parameters is mainly undertaken separately at different
times, leading to a possible bias in the epileptic focus localization. The
possibility given by the recent PET/MR scanners of simultaneous func-
tional acquisitions (such asmetabolismwith 18F-FDG PET and perfusion
with ASL MR) can allow a proper comparison between them, as the ac-
quisitions occur under the same physiological or pathophysiological
conditions. The advantages of this simultaneous acquisition are ex-
tremely helpful in epilepsy, which is probably one of the ﬁeld that
could gain more from PET/MR acquisitions as the events under study
in this pathology, such as spikes and spikes-waves, are often paroxysmsTable 4
Cross subject Spearman's rs correlation (column 1 and 2) andWilcoxon signed-ranks test
results (column 3 and 4) between SUVr and rCBF values in 10 regions of interest.
Region of interest Correlation p-Value Wilcoxon test p-Value
Frontal 0.64 0.021 −1.87 0.080
Temporal 0.58 0.042 −1.42 0.128
Occipital 0.49 0.101 −2.55 0.011
Parietal 0.54 0.049 −3.04 0.002
Cerebellum 0.28 0.353 −1.93 0.057
Striata 0.59 0.040 −2.90 0.004
Thalamus 0.27 0.363 −2.69 0.007
Hippocampus 0.55 0.045 −1.57 0.120
Insula 0.21 0.475 −1.55 0.120
Precuneus 0.46 0.115 −2.76 0.006that might change rapidly over time. With the hybrid system, the
epileptic patient can be evaluated under identical conditions, being
sure that any physiological or pathological event is “captured” by each
imaging technique at the same moment. Although areas of hypoperfu-
sion and hypometabolism cannot be expected to perfectly overlap,
due to different technical and physiological parameters aswell as differ-
ent underlying mechanisms (Leybaert, 2005), we found perfusion/
metabolism coupling in the majority (16/20) of our patients, whereas
the area of hypometabolismwasmore circumscribed than the hypoper-
fusion area in the remaining. Previous studies also reported the pres-
ence of uncoupled metabolism/perfusion pattern in drug-resistant
epilepsy (Gaillard et al., 1995), although inmany cases there was a larg-
er hypometabolic area than hypoperfusion area (Bouilleret et al., 2002).
The simultaneous evaluation of both parameters indicates the vascular
bed is impaired while the metabolism is still preserved suggesting
that ﬂow alterations might precede metabolic changes. Moreover, the
larger areas of perfusion alterations might indicate not only the region
of seizure origin but also the seizure propagation pathways, suggesting
the presence of a complex altered network. When statistically compared,
data showed an overall good correlation between rCBF, as measured by
ASL, and SUVr, asmeasuredby 18F-FDGPET/MR,withpresence of regional
variability and the highest correlations between themean rCBF and SUVr
values across patients in frontal and temporal lobes. Our results are in
agreement with previous published data (Cha et al., 2013) correlating
cerebral perfusion from ASL and glucose metabolism from 18F-FDG PET/
CT acquired in separate sessions in normal volunteers. They showed
that, despite an overall good correlation between perfusion and metabo-
lism in healthy controls, there was considerable regional variability with
seemingly ‘uncoupled’ perfusion and metabolism in medial structures
which may exist as a normal phenomenon or may be attributed to tech-
nical and acquisition parameters.
An important point of clinical relevance is that our study further
demonstrates the feasibility of ASL as an important presurgical epilepsy
tool. 18F-FDG PET, looking for a focal area of hypometabolismduring the
interictal phase, is a well-establishedmethod for the presurgical epilep-
sy evaluation in clinical practice, especially if structural MR is negative
or is discordant with the clinical hypothesis. Conversely, despite the
promising results recently shown in literature (Storti et al., 2014;
Blauwblomme et al., 2014; Boscolo Galazzo et al., 2015; Sierra-Marcos
et al., 2016), the application of ASL for epileptic patients' evaluation in
clinical practice is still limited. Here, we aimed to further demonstrate
its reliability and applicability (using the manufacturer's ASL sequence,
Fig. 3. Regional comparison across the twenty patients for ten regions of interest. A) 18F-FDG PET/CT vs 18F-FDG PET/MR; B) ASL vs 18F-FDG PET/MR.
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medicine techniques in some cases or a complementary method to
derive a more complete picture of the pathological changes. Indeed,
the good concordance between 18F-FDG PET and ASL results shown in
our group of patients indicates that it is viable to apply ASL, looking
for focal hypoperfusion during the interictal phase, instead of using
18F-FDG PET, which may not be available in all centres, or for limiting
its application, as it exposes the patient to radiations. Thus, there is a
marked ASL potential in the presurgical work up of patients who have
normal MR (or MR ﬁndings that are discordant from electro-clinical di-
agnostic hypothesis) in helping to localize the epileptic focus, as shown
by our results.
In this study, besides assessing the information provided by the two
neuroimaging techniques, we also addressed the more technical and
clinically important problem of analyzing individual patient data. In-
deed, in the case of epilepsy, group analyses are often precluded and
each patient has to be singularly evaluated to identify the possible
areas of functional alterations related to the epileptic focus. In this
ﬁeld, computer-aided diagnosis tools are increasingly relied upon in
order to more reliably interpret brain images and to obtain objective
and observer-independent information for each patient, allowing an in-
crease in the specialist's conﬁdence in image reporting. However, all the
main tools that have been successfully applied to deal with these prob-
lems, even in clinical settings, like SPM, 3D-SSP/Neurostat, Scenium
(Siemens AG, New York, NY) and Cortex ID (GE Healthcare), involve
the statistical comparison to a reference age-matched control group,
data that however is not yet widely available nor easy to acquire for
18F-FDG PET/MR. Here we propose an alternative method to identify
at patient level the areas of statistically signiﬁcant changes without
using the information derived from a normal database and we demon-
strate its usefulness as a reliable statistical analysis tool to support the vi-
sual image interpretation performed by clinical readers. This is mainly
based on the voxelwise calculation ofmetabolism/perfusion asymmetries
between the two hemispheres, a parameter (AI) that has already been
successfully applied in previous papers (Wolf et al., 2001; Duncan et al.,
1993; Theodore et al., 1997) and is clinically relevant to detect focal ab-
normalities in this patient population. Previous studies using the AI
index generally compared the estimated AI values to a reference thresh-
old derived from a normal population to identify the signiﬁcant voxels
(Leiderman et al., 1992; Ding et al., 2014) or only qualitative evaluated
the asymmetries between speciﬁc regions over the presumed epileptic
focus (Wolf et al., 2001), without providing statistical signiﬁcance to the
results. In our case, since no control group were available for any of the
three modalities, we overcame this limitation applying an individually-
tailored z-score test to the estimated AI values, using the informationestimated from each patient to automatically identify areas with statisti-
cally signiﬁcant asymmetries. This tool enhanced readers' initial visual
judgment, improving their conﬁdence in the majority of patients or
streamlining more restricted brain areas for a more precise assessment
of functional changes that are often difﬁcult to be clearly localized, espe-
cially in the case of ASL. Indeed, mainly due to the low signal-to-noise
ratio of ASL and its high sensitivity to motion artefacts, CBF maps might
be difﬁcult to assess visually, especially if the reader has limited experi-
ence with this relative new technique. Therefore, the interpretation of
ASL results at patient level as well as those coming from 18F-FDG PET
can take advantage of the support of a statistical analysis tool such as
theAI z-scores. The information providedby zAImaps resulted in a change
of theﬁnal decision in N10% of patients for both 18F-FDG PET/MR andASL,
resulting in the two modalities becoming concordant with the electro-
clinical diagnosis in all cases. In particular, patient #4 had metabolism
and perfusion visually considered unremarkable, but zAI maps showed
overlapping regions of metabolic and perfusion abnormality that allowed
a revised ﬁnal diagnosis which was concordant with the electro-clinical
diagnosis. Our consistent results across the modalities suggest that, even
in absence of a comparable normal database derived by healthy volun-
teers, zAI is a valid supportive tool for readers reporting different imaging
studies of individuals with well-lateralised disease, such as focal epilepsy.
Regarding the concordance with the electro-clinical MDT diagnosis,
18F-FDG PET/MR and ASL ﬁnal decisions were fully concordant with
MDT in lateralisation in all patients. For the localisation, 18F-FDG PET/
MR was in better agreement with the clinical hypothesis than ASL (15
vs 13). However, the perfect concordance between several modalities
achieved in 13/18 patients increases the conﬁdence in focus localisation
inMR-negative epileptic patients, improving preparation for intracrani-
al electrode implantations if deemed necessary (Brodbeck et al., 2010)
and, in selected cases, possibly leading to resective surgery without fur-
ther invasive recording.
As secondary aim, we also focused on the qualitative and quantita-
tive comparison between the 18F-FDG PET component of PET/CT and
PET/MR, evaluating the effects of the different photon attenuation cor-
rection used in the two hybrid devices. Although the advantages in si-
multaneous acquisition of PET and MR data are numerous, the major
challenge with this new system is the lack of an optimal MR sequence
to clearly measure the bone information, as in the case of CT systems,
in order to have an accurate correction of PET photon attenuation.
This aspect is particularly important in the brain, which is completely
surrounded by bone and where quantitative assessment of PET data
may be affected (Dickson et al., 2014; Burgos et al., 2014). In our study
we used the UTE sequence for the MR-based attenuation correction,
which has been shown to lead to signiﬁcant improvements in the
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bone information (Keereman et al., 2010). Looking at the 18F-FDG activ-
ity concentration, we found in all patients a consistent underestimation
for 18F-FDG PET/MR in comparison to 18F-FDGPET/CT inmost of the cor-
tical areas [results not shown], in agreementwith several previous brain
studies involving 18F-FDG PET/MR (Dickson et al., 2014; Al-Nabhani
et al., 2014). However, when we calculated SUVr maps for both modal-
ities and statistically compared the results, we found signiﬁcant correla-
tions between SUVr values of PET/CT and PET/MR in each ROI and an
overall high Pearson's correlation coefﬁcient across all the ROIs of the
twenty patients. Only few regions showed a signiﬁcant difference in
the mean SUVr values between the two modalities. Our results are in
line previous studies having the same aim (Catana et al., 2010; Berker
et al., 2012; Dickson et al., 2014), which all reﬂect an overestimation
of SUVr PET/MR in hippocampus and subcortical areas, such as thala-
mus, and an underestimation in other cortical areas, as occipital lobe,
when compared with SUVr PET/CT, which is considered the reference
standard for attenuation correction. However, these elements and dif-
ferences did not impact onto the clinical interpretations of data. We
found an excellent overall agreement between the clinical evaluations
of 18F-FDG PET/CT and 18F-FDG PET/MR images performed by the two
readers in consensus, which was almost perfect for visual evaluation
and perfect for ﬁnal decision (visual + zAI), as shown by the Kappa
test. Moreover, the two modalities have highly correlated AI maps and
lead to similar zAI statistical maps, both in terms of values and distribu-
tion, further conﬁrming the good agreement between them. Thus, de-
spite the different PET activity, the information provided by the two
modalities was highly correlated and the local metabolic alterations
well measured with 18F-FDG PET/MR.
Althoughwe proved that simultaneous 18F-FDG PET/MR is a feasible
technique to study individuals with focal refractory epilepsy, we recog-
nise some limitations. Firstly, in this difﬁcult to control group of patients
with normal MR scans, we lack a gold-standard in most of the cases,
who have not yet gone for surgery, and no histopathological conﬁrma-
tion or outcomedata are available.We have to rely on the diagnostic hy-
pothesis reached by a consensus panel and based on uncertainties
derived fromclinical and electrophysiological data such as seizure semi-
ology, neuropsychology and long-term VT-EEG. Although most of the
patients included in the present study are nowawaiting further invasive
EEG recording, only one of our patients had undergone the surgical pro-
cedure, conﬁrming the SOZ suggested by PET/MR. However, the good
concordance between the electro-clinical data and the functional
imaging data fore-assured the clinicians, leading now to the planning
of invasive tests for themajority of the patients. Secondarily, the sample
of this study is small, as we restricted the selection to the group of MR-
negative patients but well-deﬁned clinical diagnostic hypothesis about
lateralisation. More studies on larger, less selected groups are necessary
to further evaluate the performance of each modality and to better as-
sess the added value of a multimodal simultaneous imaging approach.5. Conclusion
This is the ﬁrst study to our knowledge that combines a simulta-
neous multimodality approach to evaluate cerebral perfusion with
glucose metabolism in a well-selected patient population with MR-
negative refractory focal epilepsy. The AI z-score is a valuable and useful
statistical analysis tool that increases the conﬁdence of the neuroimag-
ing reader, especially for ASL data. Even supported by this automated-
aided tool, the simultaneous acquisition ofmetabolismandperfusion pro-
vides excellent concordance on lateralisation and good concordance on
localisation of epileptic focus. Furthermore, the imaging ﬁndings from
PET/MR concurred with the electro-clinical hypothesis in the majority of
patients, providing concordant and complementary information useful
for the management of this difﬁcult-to-treat population. Therefore, in
the absence of a non-invasive gold standard, multimodality imagingallows for a more comprehensive evaluation and can contribute to a
better assessment of the epileptogenic focus.Conﬂict of interest
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